New Alzheimer’s drug could be ‘devastating’ for Medicare
Aduhelm is the first drug to target Alzheimer’s disease in nearly 20 years and will have cascading effects on health care costs.
Today's Liberal News
By Katherine Ellen Foley, David Lim and Rachel Roubein
New Alzheimer’s drug could be ‘devastating’ for Medicare
Aduhelm is the first drug to target Alzheimer’s disease in nearly 20 years and will have cascading effects on health care costs.
New Alzheimer’s drug could be ‘devastating’ for Medicare
Aduhelm is the first drug to target Alzheimer’s disease in nearly 20 years and will have cascading effects on health care costs.
New Alzheimer’s drug could be ‘devastating’ for Medicare
Aduhelm is the first drug to target Alzheimer’s disease in nearly 20 years and will have cascading effects on health care costs.